BirchBioMed
BirchBioMed is raising funds through Reg A+ crowdfunding with Dealmaker Securities as the Broker-Dealer. It is a clinical-stage biopharmaceutical company focused on developing treatments for scarring and related skin disorders. BirchBioMed has exclusive and worldwide pharmaceutical licenses from UBC for the scientific technologies FS1/FS2 and AI-001 that hold the potential for medical breakthroughs in the treatment of certain debilitating conditions. Mark S. Miller and Susan Elliott founded BirchBioMed in 2015. The current crowdfunding campaign has a maximum target of $10.35 million. The campaign proceeds will be used to complete Phase 2b and Phase 3 clinical trials for the use of FS2, design and submit to HC for the approval of Phase 1b and Phase 2a trials of AI-001, prepare applications for orphan drug designations, commercialization efforts, and working capital purposes.
Investment Overview
Raised: $220,910
Deal Terms
Total Commitments ($USD)
- Platform
- DealMaker Securities
- Start Date
- 10/08/2024
- Close Date
- Not Provided
$1,035
$10,350,000
$1,035
Equity - Common
Series A
RegA+
$5.00
$164,423,910
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $596,000
- Grants
- $600,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 10/08/2025 | DealMaker Securities | $164,423,910 | $220,910 | Equity - Common | Active | RegA+ |